Methods for preventing an immunoglobulin e-related disease
AssigneeMy-Or Diagnostics Ltd.
InventorsRon Kohn, Michael Brandwein, Ariel Katz
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of selecting and preventing an IgE-related disease in a subject in need thereof, the method including: (a) selecting a subject at risk of developing an IgE-related disease; and (b) topically administering to the subject a therapeutically effective amount of a composition capable of restoring skin barrier and orally administering to the subject a therapeutically effective amount of a composition including an allergen.
Claims7
A method for reducing the susceptibility, delaying, suppressing, or treating an IgE-related disease selected from the group consisting of:
- atopic dermatitis, allergic asthma, allergic rhinitis, food allergy, eczema, lupus, rheumatoid arthritis, psoriasis, psoriasis vulgaris, acne, acne vulgaris, rosacea, skin and soft tissue infections, dandruff, blepharitis, tinea versicolor, and any combination thereof, in a subject, the method comprising:
- a. selecting a subject at risk of developing an IgE-related disease;
- and
- b. topically administering to said subject a therapeutically effective amount of a composition comprising acemannan in an amount ranging from 0.1 to 1.0% w/w and orally administering to said subject a therapeutically effective amount of a composition comprising peanut protein, and wherein said topically administering, orally administering, or both, starts when said subject is one year old, at most,
- thereby reducing susceptibility, delaying, suppressing, or treating an IgE-related disease in the subject.
Dependencies are inferred from the claim text.